Synflex | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Synflex
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Synflex

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 22 USDMF, 8 CEP/COS, 3 EU WC, 34 KDMF, 10 NDC API, 11 Listed Suppliers, $ API Reference Price

61 API Suppliers
22 USDMF
8 CEP/COS
3 EU WC
34 KDMF
10 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

46 Drugs in Development

46 Drugs in Development

FINISHED DOSAGE FORMULATIONS

153 FDF Dossiers, 85 FDA Orange Book, 11 Europe, 18 Canada, 4 South Africa, 35 Listed Dossiers

153 FDF Dossiers
85 FDA Orange Book
11 Europe
18 Canada
4 South Africa
35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 500MG BASE, TABLET;ORAL - 220MG, TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE, CAPSULE;ORAL - EQ 200MG BASE, TABLET;ORAL - 500MG;EQ 85MG BASE, TABLET;ORAL - 60MG;EQ 10MG BASE

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 500MG BASE
TABLET;ORAL - 220MG
TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE
CAPSULE;ORAL - EQ 200MG BASE
TABLET;ORAL - 500MG;EQ 85MG BASE
TABLET;ORAL - 60MG;EQ 10MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 11 Evonik, 3 Rochem International Inc, 20 SPI Pharma, 12 DKSH, 11 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 33 BASF, 1 CD Formulation, 3 Clariant, 17 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 22 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 38 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

92 Fillers, Diluents & Binders, 64 Coating Systems & Additives, 50 Thickeners and Stabilizers, 45 Disintegrants & Superdisintegrants, 44 Controlled & Modified Release, 40 Solubilizers, 40 Direct Compression, 34 Granulation, 34 Parenteral, 29 Film Formers & Plasticizers, 26 Taste Masking, 26 Topical, 23 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 12 Rheology Modifiers, 10 Emulsifying Agents, 9 Empty Capsules, 8 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

92 Fillers, Diluents & Binders
64 Coating Systems & Additives
50 Thickeners and Stabilizers
45 Disintegrants & Superdisintegrants
44 Controlled & Modified Release
40 Solubilizers
40 Direct Compression
34 Granulation
34 Parenteral
29 Film Formers & Plasticizers
26 Taste Masking
26 Topical
23 Lubricants & Glidants
21 Chewable & Orodispersible Aids
16 Co-Processed Excipients
12 Rheology Modifiers
10 Emulsifying Agents
9 Empty Capsules
8 API Stability Enhancers
6 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

44 News #PharmaBuzz

44 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 8 Regulatory FDF Prices

14 US Medicaid Prescriptions
8 Regulatory FDF Prices

MARKET PLACE

39 APIs, 2 FDF Dossiers

39 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 4 Health Canada Patents

12 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 Others

3 EDQM
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 36 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 2Kirby Eades Gale Baker

02 1McNeil Consumer Healthcare, division of Johnson & Johnson Inc.

03 1Smart & Biggar

filter Patent Reset all filters

4 All

01 22034096

02 12509023

03 12690488

filter Product Reset all filters

4 All

01 1NAPROXEN | NAPROXEN SODIUM

02 2Naproxen Sodium

03 1SUMATRIPTAN SUCCINATE | NAPROXEN SODIUM

filter Dosage Reset all filters

4 All

01 1CAPSULE

02 2Sustained Release Tablet

03 1TABLET

filter Exp Date Reset all filters

4 All

01 22011-01-14

02 12023-12-22

03 12030-01-19

Product Main Page

01

McNeil Consumer Healthcare, division of Jo...

Naproxen, Naproxen Sodium

Peptide Process CMC

Not Confirmed

McNeil Consumer Healthcare, divisio...

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-19

Date Granted : 2013-06-11

Naproxen, Naproxen Sodium

Brand Name : 12 HOUR BODY LIQUID GELS

Patent Number : 2690488

Filing Date : 2010-01-19

Strength per Unit : 105 mg / 105 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-19

Date Granted : 2013-06-11

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

Kirby Eades Gale Baker

Naproxen Sodium

Peptide Process CMC

Not Confirmed

Kirby Eades Gale Baker

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-01-14

Date Granted : 2002-03-26

Naproxen Sodium

Brand Name : NAPRELAN

Patent Number : 2034096

Filing Date : 1991-01-14

Strength per Unit : 375 mg

Dosage Form : Sustained Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-01-14

Date Granted : 2002-03-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Kirby Eades Gale Baker

Naproxen Sodium

Peptide Process CMC

Not Confirmed

Kirby Eades Gale Baker

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-01-14

Date Granted : 2002-03-26

Naproxen Sodium

Brand Name : NAPRELAN

Patent Number : 2034096

Filing Date : 1991-01-14

Strength per Unit : 500 mg

Dosage Form : Sustained Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-01-14

Date Granted : 2002-03-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Smart & Biggar

Sumatriptan, Naproxen Sodium

Peptide Process CMC

Not Confirmed

Smart & Biggar

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-12-22

Date Granted : 2011-05-24

Sumatriptan, Naproxen Sodium

Brand Name : SUVEXX

Patent Number : 2509023

Filing Date : 2003-12-22

Strength per Unit : 85 mg / 500 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-12-22

Date Granted : 2011-05-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!